4.45 USD
↗ 0.05 (1.14%)AT CLOSE (11:59 AM EDT)
Quoin Pharmaceuticals, Ltd. American Depositary Shares
QNRXNASDAQ • USD
4.39
↘ 0.06 (1.26%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
4.39
↘ 0.06 (1.26%)
Market: CLOSED
QNRX is currently priced at $4.45. QNRX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 31, 2026.
Open?$4.17
High?$4.47
Low?$4.17
Prev. Close?$4.40
Volume?7.3K
Avg. Volume?467.6K
VWAP?$4.33
Rel. Volume?0.02x
Bid / Ask
Bid?$3.60 × 100
Ask?$5.12 × 100
Spread?$1.52
Midpoint?$4.36
Valuation & Ratios
Market Cap?8.9M
Shares Out?2.0M
P/E Ratio?N/A
P/B Ratio?1.02
EPS?-$8.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
8.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?70
Piotroski F-Score?0/9Weak
Altman Z-Score?-8.91Distress
Confidence?43%Low
Short InterestModerate
Short Interest?156.3K
Days to Cover?3.9
Avg Daily Volume40.0K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.87Strong
Quick Ratio?2.87Strong
Cash Ratio?0.58Adequate
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.02CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-193.7%WEAK▾
S&P3
ROA?-108.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$7.0M
Fundamentals ratios updated end of day